tetano
Editor, Senior Moderator
J Neurovirol
. 2021 Apr 19.
doi: 10.1007/s13365-021-00979-9. Online ahead of print.
Central nervous system vasculopathy associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a novel case report from Iran
Mohammad Javad Hosseini[SUP] #[/SUP][SUP] 1 [/SUP], Mehrdad Halaji[SUP] #[/SUP][SUP] 2 [/SUP], Javad Hosseini Nejad[SUP] 3 [/SUP], Reza Ranjbar[SUP] 4 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents respiratory symptoms as the most common clinical manifestations. Similar to some other viral infections, it can cause severe neurological damages. Here, we describe a 40-year-old man case who initially was admitted to a major hospital with presenting 7 days with weak flu-like symptoms (cough) and fever then presented neurology signs for 3 days. Physical examination and brain magnetic resonance imaging (MRI) showed cerebral vasculopathy. Molecular testing was performed on nasopharyngeal swab by real-time reverse transcription polymerase chain reaction (RT-PCR) which was positive for SARS-CoV-2. The patient received supportive cares and was treated with routine antiplatelet therapy. He was improved and discharged 10 days after admission with no symptoms. Our findings report a 40-year-old man with flu-like symptoms that indicate cerebral vasculopathy that was discharged with no symptoms. Therefore, physicians should be monitor patients with worsening or progressive central nervous system results. The pathobiology of this virus is still incompletely known; therefore, extensive studies are needed to reveal the effect of COVID-19 on the nervous system.
Keywords: COVID-19; Central nervous system; Iran; SARS-CoV-2; Vasculopathy.
. 2021 Apr 19.
doi: 10.1007/s13365-021-00979-9. Online ahead of print.
Central nervous system vasculopathy associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a novel case report from Iran
Mohammad Javad Hosseini[SUP] #[/SUP][SUP] 1 [/SUP], Mehrdad Halaji[SUP] #[/SUP][SUP] 2 [/SUP], Javad Hosseini Nejad[SUP] 3 [/SUP], Reza Ranjbar[SUP] 4 [/SUP]
Affiliations
- PMID: 33876411
- DOI: 10.1007/s13365-021-00979-9
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents respiratory symptoms as the most common clinical manifestations. Similar to some other viral infections, it can cause severe neurological damages. Here, we describe a 40-year-old man case who initially was admitted to a major hospital with presenting 7 days with weak flu-like symptoms (cough) and fever then presented neurology signs for 3 days. Physical examination and brain magnetic resonance imaging (MRI) showed cerebral vasculopathy. Molecular testing was performed on nasopharyngeal swab by real-time reverse transcription polymerase chain reaction (RT-PCR) which was positive for SARS-CoV-2. The patient received supportive cares and was treated with routine antiplatelet therapy. He was improved and discharged 10 days after admission with no symptoms. Our findings report a 40-year-old man with flu-like symptoms that indicate cerebral vasculopathy that was discharged with no symptoms. Therefore, physicians should be monitor patients with worsening or progressive central nervous system results. The pathobiology of this virus is still incompletely known; therefore, extensive studies are needed to reveal the effect of COVID-19 on the nervous system.
Keywords: COVID-19; Central nervous system; Iran; SARS-CoV-2; Vasculopathy.